Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!
Fusion Pharmaceuticals Incorporated (FUSN) Financial results for the second quarter of 2020
Net loss - $18.91 per share, with consensus forecast - $0.49.
The company holds cash of $319 million.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей
Загрузка...